Join

Compare · CCEL vs GBNH

CCEL vs GBNH

Side-by-side comparison of Cryo-Cell International Inc. (CCEL) and Greenbrook TMS Inc. (GBNH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CCEL and GBNH operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
  • CCEL is the larger of the two at $83.3M, about 1.2x GBNH ($69.8M).
  • CCEL has hit the wire 2 times in the past 4 weeks while GBNH has been quiet.
MetricCCELGBNH
Company
Cryo-Cell International Inc.
Greenbrook TMS Inc.
Price
$3.59-2.18%
$0.12-39.60%
Market cap
$83.3M
$69.8M
1M return
+16.56%
-
1Y return
-36.46%
-
Industry
Misc Health and Biotechnology Services
Misc Health and Biotechnology Services
Exchange
NASDAQ
NASDAQ
IPO
2022
News (4w)
2
0
Recent ratings
0
0
CCEL

Cryo-Cell International Inc.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

GBNH

Greenbrook TMS Inc.

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Latest CCEL

Latest GBNH